bad things about glp 1 GLP-1 Drugs and Eating Disorders: A Hidden Risk in the Weight Loss Revolution – The Chicago Council on Science and Technology GI Adverse Effects of Glucagon-Like
Description
PBM pricing
President Trump recently announced a deal with drugmakers to expand access to GLP-1 drugs to Medicare patients starting in 2026
Inside, we cover the heavy hitters everyone's watching: Semaglutide, Tirzepatide, and the one to keep your eye on next, Orforglipron (Foundayo)
Ozempic dosing begins low and increases gradually over 4 months to maximize weight loss while minimizing side effects
